Fact: FDA ' aggress Rental Birthday Jumper action in thi case demonstr the high standard to which all prescript drug ? gener and brand name ? ar held.
Gener drug ar import option that allow greater access to health care for all Americans. The popular of gener drug ha recent reach such an extent that more and more prescript fill ar done for gener drug and not for the brand ones.
safety,Gener drug ar bioequival to brand-nam drug and ar the same in dosag form. strength, rout of administration, quality, perform characterist and intend use. Today, 7 in 10 prescript fill in the Unite State ar for gener drugs. Thi articl explain about the natur of gener drug and debunk some common myth regard these medications.
Myth: Gener medic ar not as safe as brand-nam drugs.
gener ar as safe and effect as their brand-nam equivalents. The report side effect evok by gener medic ar gener the same as those that have alreadi been known for brand-nam drugsFact: Sinc gener contain the same activ ingredi as their brand-nam counterpart and work the same wai in the body..
Myth: Gener drug differ from the brand name counterpart by up to 45 percent.
Fact: Thi claim is false. All the clinic trial and investig perform dure the period of approxim the last ten year show onli 3.5 percent differ in the absorpt of gener and brand drug by the body. Everi gener ha it refer brand medic and is requir to work with the same effici with a slight allow for variability.
Myth: Gener drug ar made by less reliabl manufactur therefor these product ar cheaper than brand drugs.
not becaus the product ar of lesser quality,Fact: Gener manufactur ar abl to sell their product for lower prices. but becaus gener manufactur gener do not engag in costli advertising, market and promotion, or signific research and development. Furthermor mani of the gener drug approv and manufactur by compani that make brand name drug as well.
Myth: There ar qualiti problem with gener drug manufacturing. A recent recal of gener Digoxin Digitek show that gener drug put patient at risk.
Friday, June 4, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment